We assessed the potential of retinal organoids for optimizing CRISPR-Cas9-mediated gene editing, focusing on the therapeutically relevant RHO gene implicated in autosomal dominant retinitis pigmentosa (adRP). The gene discussed is RHO; the disease is autosomal dominant retinitis pigmentosa.